Stonepine Capital Management’s TELA Bio TELA Stock Holding History

Stonepine Capital Management’s Portfolio TELA Stock Details TELA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.62M	Buy	2,617,252 +265,220	+11%	+$230K	0.65%	25
2025 Q4	$2.78M	Buy	2,352,032 +196,513	+9%	+$249K	2.03%	14
2025 Q3	$3.21M	Buy	2,155,519 +71,757	+3%	+$126K	2.61%	13
2025 Q2	$4.04M	Buy	2,083,762 +28,537	+1%	+$37.4K	3.97%	8
2025 Q1	$2.51M	Sell	2,055,225 -297,874	-13%	-$732K	2.44%	16
2024 Q4	$7.11M	Buy	2,353,099 +1,243,099	+112%	+$3.5M	5.74%	3
2024 Q3	$2.81M	Buy	1,110,000 +484,355	+77%	+$1.72M	1.77%	20
2024 Q2	$2.94M	Sell	625,645 -62,555	-9%	-$330K	2.68%	8
2024 Q1	$3.9M	Buy	688,200 +370,418	+117%	+$2.44M	3.1%	7
2023 Q4	$2.1M	Sell	317,782 -174,137	-35%	-$1.01M	0.91%	13
2023 Q3	$3.94M	Buy	491,919 +9,300	+2%	+$86.4K	1.31%	16
2023 Q2	$4.89M	Buy	+482,619	New	+$4.94M	1.76%	14

Other funds holding TELA

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stonepine Capital Management's TELA Position: Q1 2026 in Review

Stonepine Capital Management increased its TELA Bio (TELA) stake by 11% in Q1 2026, buying an estimated $230K and bringing the position to 2,617,252 shares worth $1.62M. The position accounts for 0.65% of the portfolio, ranked #25.

Stonepine Capital Management first reported a position in TELA in Q2 2023 and has held it in 12 quarters since. The position peaked at $7.11M in Q4 2024. 36 funds tracked by Wall St. Rank hold TELA as of Q1 2026.

Stonepine Capital Management held 2,617,252 shares of TELA Bio worth $1.62M as of Q1 2026.
Stonepine Capital Management bought 265,220 TELA Bio shares in Q1 2026, an estimated $230K.
TELA Bio made up 0.65% of Stonepine Capital Management's portfolio in Q1 2026, its #25 holding.
Stonepine Capital Management first reported a position in TELA Bio in Q2 2023 and has held it in 12 quarters since.
Stonepine Capital Management's TELA Bio position peaked at $7.11M in Q4 2024.
36 funds tracked by Wall St. Rank held TELA Bio as of Q1 2026.

Based on Stonepine Capital Management's 13F filing for Q1 2026, filed 14 May 2026.